课题基金 / 基金详情

Plasma biomarkers of Alzheimer's disease in insomnia before and after cognitive behavioral therapy for insomnia

Plasma biomarkers of Alzheimer's disease in insomnia before and after cognitive behavioral therapy for insomnia
失眠认知行为治疗前后阿尔茨海默病失眠的血浆生物标志物
批准号:
484666
负责人:
Baril Andre-Ann
金额:
$14.47万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-11-01 至 2025-11-01

项目摘要

项目成果

Baril Andre-Ann的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Insomnia, one of the most common and treatable sleep disorders, could increase the risk for Alzheimer's disease. In fact, insomnia could be an additional insult to the aging brain and contribute to neurodegeneration. Whether insomnia before and after trea
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
72th Lindau Nobel Laureate Meeting Travel Award Recipient
  • 批准号:
    485240
  • 项目类别:
  • 资助金额:
    $0.36万
  • 财政年份:
    2022
  • 负责人:
    Baril Andre-Ann
  • 依托单位:
The circadian clock and Alzheimer's disease pathology
  • 批准号:
    436296
  • 项目类别:
    Fellowship Programs
  • 资助金额:
    $10.2万
  • 财政年份:
    2020
  • 负责人:
    Baril Andre-Ann
  • 依托单位:
Interaction of sleep disturbances with neurodegenerative, inflammatory, and metabolic blood-based biomarkers on the risk of incident dementia - Framingham Heart Study
  • 批准号:
    376596
  • 项目类别:
    Fellowship Programs
  • 资助金额:
    $10.93万
  • 财政年份:
    2017
  • 负责人:
    Baril Andre-Ann
  • 依托单位:
海外基金